7096 Share Price Performance
JP¥917.00
-744.00 (-44.79%)
Price JP¥917.00
Share PriceJP¥917.00
These 4 Measures Indicate That StemCell Institute (TSE:7096) Is Using Debt Reasonably Well
Apr 10
StemCell Institute Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
7096 Community Narratives
There are no narratives available yet.
Recent 7096 News & Updates
StemCell Institute Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 12, 2025
- Earnings per share (EPS)
- 24.40
- Gross Margin
- 62.35%
- Net Profit Margin
- 9.26%
- Debt/Equity Ratio
- 18.2%
StemCell Institute Inc. Competitors
Snowflake Analysis
About 7096
- Founded
- 1999
- Employees
- 117
- CEO
- WebsiteView website
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Japanese Market Performance
- 7 Days: -1.8%
- 3 Months: 10.3%
- 1 Year: 15.3%
- Year to Date: 13.5%
Over the last 7 days, the market has dropped 1.8%, driven by declines in the Consumer Discretionary and Financials sectors of 3.6% and 4.0%, respectively. In contrast to the last week, the market is actually up 15% over the past year. Earnings are forecast to grow by 8.2% annually. Market details ›